Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-20 of 159

Sort by

Sort Order Select

Journal Articles

CAR-T cell therapy in multiple myeloma in a front-line setting: A systematic review and meta-analysis

Hafiz Muhammad Hannan Javed, Hafsa Shahid, Farooq Ashraf, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 7605.

https://doi.org/10.1182/blood-2025-7605

Published: 2025

Journal Articles

Efficacy of tocilizumab prophylaxis in preventing cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome: A systematic review and meta-analysis

Moazzam Shahzad, Hafiz Muhammad Hannan Javed, Hafsa Shahid, Anas Zayad, Rohan Parvathala, Sarmad Zaman Warraich, Muhammad Umair Mushtaq, Al-Ola Abdallah

Blood (2025) 146 (Supplement 1): 7602.

https://doi.org/10.1182/blood-2025-7602

Published: 2025

Journal Articles

Comparative safety and efficacy of bendamustine versus fludarabine/cyclophosphamide prior to chimeric antigen receptor- T cell therapy: A systematic review and meta-analysis

Muhammad Kashif Amin, Tehseen Raza, Hira Habib, Nabeeha Noor, Muhammad Usman, Fatima Imran, Rameen Fatima, Muhammad Zohaib Qasim, Hammad Shafi, Moazzam Shahzad, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 6320.

https://doi.org/10.1182/blood-2025-6320

Published: 2025

Journal Articles

Impact of early bacteremia on clinical outcomes following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based gvhd prophylaxis

Moazzam Shahzad, Shah Rukh, Aroog Khaliq, Aqeeb Ur Rehman, Amna Bint I Munir, Muhammad Kashif Amin, Amir Kasaeian, Anthony Sung, Mehdi Hamadani, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 4200.

https://doi.org/10.1182/blood-2025-4200

Published: 2025

Journal Articles

Optimal dose and duration of venetoclax for induction therapy in acute myeloid leukemia and myelodysplastic syndrome: A systematic review and meta-analysis

Mamoon Ahmed, Farooq Ashraf, Anas Al-sadi, Muhammad Shaheer Mannan, Jehad Zeidalkilani, Hafsa Shahid, Aniqa Faraz, Maheen Zahid, Aman Ullah, Sohaib Irfan, Sarmad Zaman Warraich, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 2831.

https://doi.org/10.1182/blood-2025-2831

Published: 2025

Journal Articles

Impact of donor age on transplant outcomes in unrelated allogeneic hematopoietic stem cell transplantation using post-transplant cyclophosphamide-based gvhd prophylaxis

Muhammad Kashif Amin, Moazzam Shahzad, Matthew McGuirk, Asma Zakir, Al-Ola Abdallah, Nausheen Ahmed, Sunil Abhyankar, Mehdi Hamadani, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 173.

https://doi.org/10.1182/blood-2025-173

Published: 2025

Journal Articles

Tumor-infiltrating lymphocyte therapy in lung cancer: A systematic review

Muhammad Kashif Amin, Muhammad Asad Shabbir, Nabeeha Noor, Abdullah Masood, Maham Rasool, Muhammad Ali Lak, Qasim Chohdry, Hammad Shafi, Ezza Bashir, Moazzam Shahzad, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 7692.

https://doi.org/10.1182/blood-2025-7692

Published: 2025

Journal Articles

Outcomes with itacitinib prophylaxis for cytokine release syndrome: A systematic review

Hafiz Muhammad Hannan Javed, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 7691.

https://doi.org/10.1182/blood-2025-7691

Published: 2025

Journal Articles

Outcomes after bone marrow versus peripheral blood mismatched unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

Amir Kasaeian, Moazzam Shahzad, Zeeshan Sattar, Muhammad Kashif Amin, Hediyeh Alemi, Forat Lutfi, Mehdi Hamadani, Rajat Bansal, Alma Habib, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 934.

https://doi.org/10.1182/blood-2025-934

Published: 2025

Journal Articles

Incidence, patterns, and outcomes of adenovirus infections in patients following allogeneic hematopoietic cell transplantation

Areeba Ismail, Amna Bint I Munir, Fatima Imran, Muhammad Shahzou Shah, Zunaira Amjad, Muhammad Zeeshan, Hammad Shafi, Muhammad Kashif Amin, Joseph McGuirk, Moazzam Shahzad, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 7733.

https://doi.org/10.1182/blood-2025-7733

Published: 2025

Journal Articles

Efficacy, quality of life, and safety of non-clotting factor prophylaxis in Hemophilia A and b: A meta-analysis across inhibitor status

Abdul basit Khan, Rehan Ishaque, Sibgha Fawad Memon, Zauha fawad Memon, Matia Fawad Memon, Fawad Talat, Aswanth Reddy, Madhuri yalamanchili, Muhammad Kashif Amin, Muhammad Umair Mushtaq, Moazzam Shahzad, Supratik Rayamajhi

Blood (2025) 146 (Supplement 1): 6628.

https://doi.org/10.1182/blood-2025-6628

Published: 2025

Journal Articles

Outcomes and associated factors after melphalan 140 mg/m² autologous hematopoietic cell transplantation for multiple myeloma in patients over 70 years of age

Aqeeb Ur Rehman, Moazzam Shahzad, Shah Rukh, Zeeshan Sattar, Muhammad Kashif Amin, Jeries Kort, Al-Ola Abdallah, Leyla Shune, Mehdi Hamadani, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 5985.

https://doi.org/10.1182/blood-2025-5985

Published: 2025

Journal Articles

Impact of conditioning intensity on outcomes after unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

Muhammad Kashif Amin, Moazzam Shahzad, Amir Kasaeian, Hediyeh Alemi, Asma Zakir, Haitham Abdelhakim, Anurag Singh, Mehdi Hamadani, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 505.

https://doi.org/10.1182/blood-2025-505

Published: 2025

Journal Articles

Trends in chronic lymphocytic leukemia mortality among older adults with renal failure in the United States: A 25-year retrospective study.

Muhammad Shaheer Bin Faheem, Syed Tawassul Hassan, Sai Sushrutha Mudupula Vemula, Anam Ashfaque, Fahad Nayim, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 8059.

https://doi.org/10.1182/blood-2025-8059

Published: 2025

Journal Articles

Outcomes with dasatinib in Philadelphia Chromosome–Positive acute lymphoblastic leukemia: A systematic review and meta-analysis

Muhammad Kashif Amin, Hafiz Muhammad Hannan Javed, Zeeshan Sattar, Hafsa Shahid, Mamoon Ahmed, Aman Ullah, Aminah Tayyab, Waleeh Ahmed Mir, Ruhma Sehar, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 6869.

https://doi.org/10.1182/blood-2025-6869

Published: 2025

Journal Articles

Blinatumomab vs. chemotherapy in pediatrics B-cell ALL: A meta-analysis of randomized controlled trials

Muhammad Shaheer Mannan, Abdul basit Khan, Adeena Musheer, Iqra Nadeem, Hafsa Arshad Azam Raja, Abdur-Rehman Butt, Zuhaa Hassan Kazmi, Sumia Fatima, Ahsan Iqbal, Syed Tehseen Haider, Fahd Niaz Shaikh, Noman Faisal, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 6867.

https://doi.org/10.1182/blood-2025-6867

Published: 2025

Journal Articles

Outcomes of haploidentical hematopoietic stem cell transplantation in low- and middle-income countries: A systematic review and meta-analysis.

Moazzam Shahzad, Muhammad Kashif Amin, Rehan Ishaque, Mahad Zamir, Muhammad Junaid Azhar, Syed Aftab Haider Kamran, Muhammad Abdullah, Roma Bai, Ammara Saleem, Hammad Shafi, Raheel Iftikhar, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 7816.

https://doi.org/10.1182/blood-2025-7816

Published: 2025

Journal Articles

Single-arm meta-analysis of melflufen-based regimens in relapsed/refractory multiple myeloma: Efficacy and safety insights from clinical trials

Abdul basit Khan, Fawad Talat, Zauha fawad Memon, Rehan Ishaque, Sibgha Fawad Memon, Matia Fawad Memon, Hira Rehman, Hamza Janjua, Aswanth Reddy, Muhammad Umair Mushtaq, Muhammad Kashif Amin, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 7568.

https://doi.org/10.1182/blood-2025-7568

Published: 2025

Journal Articles

Outcomes with chimeric antigen receptor-t cell therapy in relapsed/refractory b-cell acute lymphoblastic leukemia: A systematic review and meta-analysis

Hafiz Muhammad Hannan Javed, Muhammad Kashif Amin, Hafsa Shahid, Sarmad Zaman Warraich, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 6875.

https://doi.org/10.1182/blood-2025-6875

Published: 2025

Journal Articles

Outcomes with ponatinib in patients with relapsed/refractory Philadelphia-chromosome positive acute lymphoblastic leukemia: A systematic review and meta-analysis

Hafiz Muhammad Hannan Javed, Muhammad Kashif Amin, Zeeshan Sattar, Mamoon Ahmed, Aman Ullah, Aminah Tayyab, Waleeh Ahmed Mir, Fatima Sial, Ruhma Sehar, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 6873.

https://doi.org/10.1182/blood-2025-6873

Published: 2025

Update search

NARROW

Publications

Format

Article Type

Date

Availability

CAR-T cell therapy in multiple myeloma in a front-line setting: A systematic review and meta-analysis

Efficacy of tocilizumab prophylaxis in preventing cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome: A systematic review and meta-analysis

Comparative safety and efficacy of bendamustine versus fludarabine/cyclophosphamide prior to chimeric antigen receptor- T cell therapy: A systematic review and meta-analysis

Impact of early bacteremia on clinical outcomes following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based gvhd prophylaxis

Optimal dose and duration of venetoclax for induction therapy in acute myeloid leukemia and myelodysplastic syndrome: A systematic review and meta-analysis

Impact of donor age on transplant outcomes in unrelated allogeneic hematopoietic stem cell transplantation using post-transplant cyclophosphamide-based gvhd prophylaxis

Tumor-infiltrating lymphocyte therapy in lung cancer: A systematic review

Outcomes with itacitinib prophylaxis for cytokine release syndrome: A systematic review

Outcomes after bone marrow versus peripheral blood mismatched unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

Incidence, patterns, and outcomes of adenovirus infections in patients following allogeneic hematopoietic cell transplantation

Efficacy, quality of life, and safety of non-clotting factor prophylaxis in Hemophilia A and b: A meta-analysis across inhibitor status

Outcomes and associated factors after melphalan 140 mg/m² autologous hematopoietic cell transplantation for multiple myeloma in patients over 70 years of age

Impact of conditioning intensity on outcomes after unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

Trends in chronic lymphocytic leukemia mortality among older adults with renal failure in the United States: A 25-year retrospective study.

Outcomes with dasatinib in Philadelphia Chromosome–Positive acute lymphoblastic leukemia: A systematic review and meta-analysis

Blinatumomab vs. chemotherapy in pediatrics B-cell ALL: A meta-analysis of randomized controlled trials

Outcomes of haploidentical hematopoietic stem cell transplantation in low- and middle-income countries: A systematic review and meta-analysis.

Single-arm meta-analysis of melflufen-based regimens in relapsed/refractory multiple myeloma: Efficacy and safety insights from clinical trials

Outcomes with chimeric antigen receptor-t cell therapy in relapsed/refractory b-cell acute lymphoblastic leukemia: A systematic review and meta-analysis

Outcomes with ponatinib in patients with relapsed/refractory Philadelphia-chromosome positive acute lymphoblastic leukemia: A systematic review and meta-analysis

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only